Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this crucial session on understanding the current scenario of cancer. This presentation will provide a detailed overview of the incidence of cancer in men, focusing on prevalent trends, key risk factors, and the importance of early detection. Globally, cancer is a leading cause of death, and its burden on men varies significantly by region and lifestyle. Understanding the most common cancers that affect men, such as prostate, lung, and colorectal cancer, is essential for developing effective prevention and screening strategies.
The current landscape of cancer in men is characterized by the dominance of a few specific types. In many parts of the world, prostate cancer is the most frequently diagnosed cancer, while lung and bronchus cancer remains the leading cause of cancer-related deaths. Other common malignancies include colorectal cancer, oral cancer, and head and neck cancers, which are often linked to modifiable risk factors like tobacco use and alcohol consumption. A deeper look at the incidence data reveals geographical disparities, with certain regions showing higher rates of specific cancers due to unique environmental, genetic, and lifestyle factors.
Therefore, get an overall knowledge of the current scenario of cancer incidence in men. Listen to the webinar, led by Dr. Ashish Singh, absorb the shared knowledge on the latest trends and diagnostic advancements, and follow Hidoc for more such insightful webinar sessions.
See More Webinars @ Hidoc Webinars
1.
New surgical method shows promising results for cervical cancer treatment
2.
Babies Are Bleeding to Death as Parents Reject a Vitamin Shot Given at Birth
3.
GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium
4.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
5.
Can Prior Authorization Be Better With Artificial Intelligence?
1.
Checkpoint Inhibitors in Oncology: Advances in PD-1/PD-L1 and CTLA-4 Targeted Therapy
2.
Public Health Strategies for Improving Cancer Survivorship Support Systems
3.
Analyzing the Mechanisms and Efficacy of Carboplatin, Abraxane, and Albumin-Bound Formulations
4.
Treating Methemoglobinemia: What You Need to Know Now!
5.
Red Cell Deformability as a Target in Critical Illness
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
2.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
3.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
5.
Updates on Standard V/S High Risk Myeloma Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation